Literature DB >> 17410408

Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride.

Monika Bhadauria1, Satendra Kumar Nirala, Sangeeta Shukla.   

Abstract

Induction of CYP 2E1 by carbon tetrachloride (CCl(4)) is one of the central pathways by which CCl(4) generates oxidative stress in hepatocytes. Experimental liver injury was induced in rats by CCl(4) to determine toxicological actions on CYP 2E1 by microsomal drug metabolizing enzymes. In this report, ethanolic extract of propolis at a dose of 200 mg/kg (po) was used after 24 h of toxicant administration to validate its protective potential. Intraperitoneal injection of CCl(4) (1.5 ml/kg) induced hepatotoxicity after 24 h of its administration that was associated with elevated malonyldialdehyde (index of lipid peroxidation), lactate dehydrogenase and gamma-glutamyl transpeptidase release (index of a cytotoxic effect). Hepatic microsomal drug metabolizing enzymes of CYP 2E1 showed sharp depletion as assessed by estimating aniline hydroxylase and amidopyrine N-demethylase activity after CCl(4) exposure. Toxic effect of CCl(4) was evident on CYP 2E1 activity by increased hexobarbitone induced sleep time and bromosulphalein retention. Propolis extract showed significant improvement in the activity of both enzymes and suppressed toxicant induced increase in sleep time and bromosulphalein retention. Choleretic activity of liver did not show any sign of toxicity after propolis treatment at a dose of 200 mg/kg (id). Histopathological evaluation of the liver revealed that propolis reduced the incidence of liver lesions including hepatocyte swelling and lymphocytic infiltrations induced by CCl(4). Electron microscopic observations also showed improvement in ultrastructure of liver and substantiated recovery in biochemical parameters. Protective activity of propolis at 200 mg/kg dose was statistically compared with positive control silymarin (50 mg/kg, po), a known hepatoprotective drug seems to be better in preventing hepatic CYP 2E1 activity deviated by CCl(4). These results lead us to speculate that propolis may play hepatoprotective role via improved CYP 2E1 activity and reduced oxidative stress in living system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410408     DOI: 10.1007/s11010-007-9443-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  Recent progress in pharmacological research of propolis.

Authors:  A H Banskota; Y Tezuka; S Kadota
Journal:  Phytother Res       Date:  2001-11       Impact factor: 5.878

2.  Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine.

Authors:  J COCHIN; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1959-02       Impact factor: 4.030

3.  Effect of propolis extract on acute carbon tetrachloride induced hepatotoxicity.

Authors:  Sangeeta Shukla; Monika Bhadauria; Anjana Jadon
Journal:  Indian J Exp Biol       Date:  2004-10       Impact factor: 0.818

4.  Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products.

Authors:  J W Dobrowolski; S B Vohora; K Sharma; S A Shah; S A Naqvi; P C Dandiya
Journal:  J Ethnopharmacol       Date:  1991-10       Impact factor: 4.360

5.  Antimicrobial activity of propolis samples from two different regions of Anatolia.

Authors:  Murat Kartal; Sulhiye Yildiz; Serdar Kaya; Semra Kurucu; Gülaçti Topçu
Journal:  J Ethnopharmacol       Date:  2003-05       Impact factor: 4.360

6.  Effect of carbon tetrachloride on the metabolism, storage, and excretion of sulfobromophthalein.

Authors:  C D Klaassen; G L Plaa
Journal:  Toxicol Appl Pharmacol       Date:  1968-01       Impact factor: 4.219

7.  Evaluation of four prescriptions of traditional Chinese medicine: syh-mo-yiin, guizhi-fuling-wan, shieh-qing-wan and syh-nih-sann on experimental acute liver damage in rats.

Authors:  C C Tsai; C T Kao; C T Hsu; C C Lin; J G Lin
Journal:  J Ethnopharmacol       Date:  1997-02       Impact factor: 4.360

8.  Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines.

Authors:  Arjun H Banskota; Takema Nagaoka; Lucia Yoshie Sumioka; Yasuhiro Tezuka; Suresh Awale; Kiyoshi Midorikawa; Katsumichi Matsushige; Shigetoshi Kadota
Journal:  J Ethnopharmacol       Date:  2002-04       Impact factor: 4.360

9.  Protective effect of Rhodiola sachalinensis extract on carbon tetrachloride-induced liver injury in rats.

Authors:  Ji-Xing Nan; Ying-Zi Jiang; Eun-Jeon Park; Geonil Ko; Youn-Chul Kim; Dong Hwan Sohn
Journal:  J Ethnopharmacol       Date:  2003-02       Impact factor: 4.360

10.  Identification of dichloromethyl carbene as a metabolite of carbon tetrachloride.

Authors:  L R Pohl; J W George
Journal:  Biochem Biophys Res Commun       Date:  1983-12-16       Impact factor: 3.575

View more
  9 in total

1.  Experimental liver protection of n-butanolic extract of Astragalus monspessulanus L. on carbon tetrachloride model of toxicity in rat.

Authors:  Rumyana Simeonova; Viktor M Bratkov; Magdalena Kondeva-Burdina; Vessela Vitcheva; Vassil Manov; Ilina Krasteva
Journal:  Redox Rep       Date:  2014-11-14       Impact factor: 4.412

2.  Comparative anti-inflammatory and hepatoprotective activities of Astragalus gummifer Labill herb and roots in rats.

Authors:  Hasan Soliman Yusufoglu; Aftab Alam; Ahmed Mohammed Zaghloul; Mohammad Ayman Al-salkini; Prawez Alam
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

3.  Propolis prevents hepatorenal injury induced by chronic exposure to carbon tetrachloride.

Authors:  Monika Bhadauria
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-04       Impact factor: 2.629

4.  Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes.

Authors:  Chang Seon Ryu; Soo Jin Oh; Jung Min Oh; Ji-Yoon Lee; Sang Yoon Lee; Jung-Woo Chae; Kwang-Il Kwon; Sang Kyum Kim
Journal:  Toxicol Res       Date:  2016-07-30

5.  Protective Effect of Brazilian Propolis against Liver Damage with Cholestasis in Rats Treated with α-Naphthylisothiocyanate.

Authors:  Tadashi Nakamura; Yoshiji Ohta; Koji Ohashi; Kumiko Ikeno; Rie Watanabe; Kenji Tokunaga; Nobuhiro Harada
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-22       Impact factor: 2.629

6.  Effect of Croatian propolis on diabetic nephropathy and liver toxicity in mice.

Authors:  Nada Oršolić; Damir Sirovina; Marijana Zovko Končić; Gordana Lacković; Gordana Gregorović
Journal:  BMC Complement Altern Med       Date:  2012-08-06       Impact factor: 3.659

Review 7.  Some in vitro/in vivo chemically-induced experimental models of liver oxidative stress in rats.

Authors:  Rumyana Simeonova; Magdalena Kondeva-Burdina; Vessela Vitcheva; Mitka Mitcheva
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

8.  Nigerian propolis improves blood glucose, glycated hemoglobin A1c, very low-density lipoprotein, and high-density lipoprotein levels in rat models of diabetes.

Authors:  Mustafa Ibrahim Oladayo
Journal:  J Intercult Ethnopharmacol       Date:  2016-05-04

Review 9.  Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.

Authors:  Hor-Yue Tan; Serban San-Marina; Ning Wang; Ming Hong; Sha Li; Lei Li; Fan Cheung; Xiao-Yan Wen; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-28       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.